Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (156)	6/14/2019 8:49:41 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 280

Based on pre-market action today in ARQL we should see major shakeup in leader board. Bulba should keep the green jacket, but Jbob should see a $20,000+ pop in his overall valuation due to a 20% position in ARQL. Kmast is already in the top ten and he should see a $17,000+ pop(15% position) putting him up more than 50% YTD. Five others (including myself) have 10% allocations. We are coming for you Bulba--don't look back! (:>)

To: BulbaMan who wrote (156)	6/14/2019 6:56:38 PM
From: BulbaMan	Read Replies (2) \| Respond to of 280

6/14/2019 Contest update Although most biotechs faltered on Friday, a big bounce by ARQL (held in 7 Contest portfolios) helped keep the Contest median in the green for the week. At Friday’s close, the Contest median was up 10.08% YTD (vs. up 9.61% YTD a week earlier), the Nasdaq Biotech Index (NBI) was up 6.32% YTD (vs. up 7.13% YTD a week earlier) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 13.03% YTD (vs. up 15.28% YTD a week earlier), while the Nasdaq Composite Index (NCI) was up 17.50% YTD (vs. up 16.68% YTD a week earlier). Utilizing the “Sleeping Beauty” ZIOP maneuver, BULBA’s portfolio easily repelled an ARQL "BTK" attack and remained Contest leader with a 82.18% YTD gain. Still, both second place OHMS’ portfolio, up 53.00% YTD, and third place ANDRE’s portfolio, up 52.41% YTD, did get a booster blast from the ARQL rocket. At Friday's close, 30 of the 39 Contest portfolios were in the green, while 22 were beating the NBI and 16 were beating the SPSIBI. The 167 Contest stock picks have an average YTD gain of 16.62% and a median YTD gain of 4.96%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Enjoy another safe & relaxing June weekend biotechies! Peace & good health, Bulba 6/14/19 Rank Name Profit/Loss 1 BULBA 82,180 2 OHMS 53,003 3 ANDRE 52,408 4 KMASTR 47,739 5 BMAZ 44,976 6 ARTHUR 41,128 7 TRONKA 39,319 8 HOOD 37,924 9 RKRW 36,495 10 BLADE 24,706 Week's Top 5 Gainers Symbol 6/7/19 6/14/19 Wk.%chg. ARQL 6.510 8.200 25.96% ZIOP 4.180 5.220 24.88% SYBX 6.330 7.720 21.96% AFMD 2.620 3.190 21.76% APTO 1.840 2.240 21.74% Week's Worst 5 Losers Symbol 6/7/19 6/14/19 Wk.%chg. SESN 2.320 1.700 -26.72% EPZM 14.220 11.630 -18.21% PLX 0.500 0.424 -15.30% KRYS 31.520 27.200 -13.71% XENE 10.370 8.960 -13.60%